Ligand Pharmaceuticals (LGND) Capital Expenditures (QoQ) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Ligand Pharmaceuticals | 4.61 Bn | 3.83 Bn | 48.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.05% |
| Dec 31, 2025 | 150.23% |
| Sep 30, 2025 | -300.00% |
| Jun 30, 2025 | 0.00% |
| Mar 31, 2025 | 198.17% |
| Dec 31, 2024 | 99.71% |
| Sep 30, 2024 | -199.62% |
| Jun 30, 2024 | 3,749,800.00% |
| Mar 31, 2024 | 100.06% |
| Dec 31, 2023 | -220.68% |
| Sep 30, 2023 | 556.12% |
| Jun 30, 2023 | 180.00% |
| Mar 31, 2023 | 110.83% |
| Dec 31, 2022 | 83.50% |
| Sep 30, 2022 | -218.96% |
| Jun 30, 2022 | 35.14% |
| Mar 31, 2022 | 382.67% |
| Dec 31, 2021 | 123.84% |
| Sep 30, 2021 | -190.01% |
| Jun 30, 2021 | 5,310.34% |
| Mar 31, 2021 | 165.91% |
| Dec 31, 2020 | -248.31% |
| Sep 30, 2020 | -61.14% |
| Jun 30, 2020 | 263.49% |
| Mar 31, 2020 | -87.27% |
| Dec 31, 2019 | 1,016.67% |
| Sep 30, 2019 | 78.14% |
| Jun 30, 2019 | -182.06% |
| Mar 31, 2019 | 2,636.36% |
| Dec 31, 2018 | 117.74% |
| Sep 30, 2018 | -193.94% |
| Dec 31, 2017 | -73.18% |
| Sep 30, 2017 | 2,054.02% |
| Jun 30, 2017 | -200.00% |
| Mar 31, 2017 | -95.30% |
| Dec 31, 2016 | 281.19% |
| Sep 30, 2016 | -230.40% |
| Jun 30, 2016 | 228.99% |
| Mar 31, 2016 | 260.61% |
| Jun 30, 2015 | 2,900.00% |
| Mar 31, 2015 | -100.77% |
| Dec 31, 2014 | 12,900.00% |
| Sep 30, 2014 | 100.76% |
| Jun 30, 2014 | -2,283.33% |
| Mar 31, 2014 | -94.74% |
| Dec 31, 2013 | -57.14% |
| Sep 30, 2013 | 765.00% |
| Jun 30, 2013 | -208.11% |
| Mar 31, 2013 | 197.37% |
| Dec 31, 2012 | -110.22% |
| Sep 30, 2012 | 53.72% |
| Jun 30, 2012 | 1,173.68% |
| Mar 31, 2012 | 150.00% |
| Dec 31, 2011 | -134.23% |